These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 7810805)

  • 21. Antibody responses to the repetitive Plasmodium falciparum antigen Pf332 in humans naturally primed to the parasite.
    Ahlborg N; Haddad D; Siddique AB; Roussilhon C; Rogier C; Trape JF; Troye-Blomberg M; Berzins K
    Clin Exp Immunol; 2002 Aug; 129(2):318-25. PubMed ID: 12165089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1.
    Cortés A; Mellombo M; Masciantonio R; Murphy VJ; Reeder JC; Anders RF
    Infect Immun; 2005 Jan; 73(1):422-30. PubMed ID: 15618180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody responses to a C-terminal fragment of the Plasmodium falciparum blood-stage antigen Pf332 in Senegalese individuals naturally primed to the parasite.
    Israelsson E; Balogun H; Vasconcelos NM; Beser J; Roussilhon C; Rogier C; Trape JF; Berzins K
    Clin Exp Immunol; 2008 Apr; 152(1):64-71. PubMed ID: 18279441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria.
    Taylor RR; Allen SJ; Greenwood BM; Riley EM
    Am J Trop Med Hyg; 1998 Apr; 58(4):406-13. PubMed ID: 9574783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of IgG responses to Plasmodium falciparum MSP1p19 and PF13-DBL1α1 using ELISA and a magnetic bead-based duplex assay (MAGPIX®-Luminex) in a Senegalese meso-endemic community.
    Perraut R; Richard V; Varela ML; Trape JF; Guillotte M; Tall A; Toure A; Sokhna C; Vigan-Womas I; Mercereau-Puijalon O
    Malar J; 2014 Oct; 13():410. PubMed ID: 25326042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgG against Plasmodium falciparum variant surface antigens and growth inhibitory antibodies in Mozambican children receiving intermittent preventive treatment with sulfadoxine-pyrimethamine.
    Quelhas D; Jiménez A; Quintó L; Serra-Casas E; Mayor A; Cisteró P; Puyol L; Wilson DW; Richards JS; Nhampossa T; Macete E; Aide P; Mandomando I; Sanz S; Aponte JJ; Alonso PL; Beeson JG; Menéndez C; Dobaño C
    Immunobiology; 2011 Jul; 216(7):793-802. PubMed ID: 21257227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.
    Polley SD; Conway DJ; Cavanagh DR; McBride JS; Lowe BS; Williams TN; Mwangi TW; Marsh K
    Vaccine; 2006 May; 24(19):4233-46. PubMed ID: 16111789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Humoral immune responses to Plasmodium falciparum antigens in children and adults living in a hypoendemic area of Punjab (Pakistan).
    Iqbal J; Rab A; Perlmann P; Berzins K
    Am J Trop Med Hyg; 1994 Oct; 51(4):444-53. PubMed ID: 7943571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigens.
    Noland GS; Jansen P; Vulule JM; Park GS; Ondigo BN; Kazura JW; Moormann AM; John CC
    Acta Trop; 2015 Feb; 142():47-56. PubMed ID: 25446174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the quality and quantity of naturally induced antibody responses to EBA175RIII-V in Ghanaian children living in two communities with varying malaria transmission patterns.
    Abagna HB; Acquah FK; Okonu R; Aryee NA; Theisen M; Amoah LE
    Malar J; 2018 Jan; 17(1):14. PubMed ID: 29310662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterisation of Plasmodium reichenowi apical membrane antigen-1 (AMA-1), comparison with P. falciparum AMA-1, and antibody-mediated inhibition of red cell invasion.
    Kocken CH; Narum1 DL; Massougbodji A; Ayivi B; Dubbeld MA; van der Wel A; Conway DJ; Sanni A; Thomas AW
    Mol Biochem Parasitol; 2000 Jul; 109(2):147-56. PubMed ID: 10960173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural antibody responses to Plasmodium falciparum MSP3 and GLURP(R0) antigens are associated with low parasite densities in malaria patients living in the Central Region of Ghana.
    Amoah LE; Nuvor SV; Obboh EK; Acquah FK; Asare K; Singh SK; Boampong JN; Theisen M; Williamson KC
    Parasit Vectors; 2017 Aug; 10(1):395. PubMed ID: 28835262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using serological measures to monitor changes in malaria transmission in Vanuatu.
    Cook J; Reid H; Iavro J; Kuwahata M; Taleo G; Clements A; McCarthy J; Vallely A; Drakeley C
    Malar J; 2010 Jun; 9():169. PubMed ID: 20553604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Naturally Acquired Antibody Responses to Two Variant Forms of Plasmodium vivax Apical Membrane Antigen-1 in Individuals Living in Areas of Low and Unstable Malaria Transmission of Iran.
    Salavatifar M; Zakeri S; Abouie Mehrizi A; Mirkhazemi S; Dinparast Djadid N
    Arch Iran Med; 2015 Dec; 18(12):834-43. PubMed ID: 26621016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum.
    Dutta S; Haynes JD; Barbosa A; Ware LA; Snavely JD; Moch JK; Thomas AW; Lanar DE
    Infect Immun; 2005 Apr; 73(4):2116-22. PubMed ID: 15784553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies against multiple merozoite surface antigens of the human malaria parasite Plasmodium falciparum inhibit parasite maturation and red blood cell invasion.
    Woehlbier U; Epp C; Hackett F; Blackman MJ; Bujard H
    Malar J; 2010 Mar; 9():77. PubMed ID: 20298576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria.
    Malkin EM; Diemert DJ; McArthur JH; Perreault JR; Miles AP; Giersing BK; Mullen GE; Orcutt A; Muratova O; Awkal M; Zhou H; Wang J; Stowers A; Long CA; Mahanty S; Miller LH; Saul A; Durbin AP
    Infect Immun; 2005 Jun; 73(6):3677-85. PubMed ID: 15908397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profiling the antibody immune response against blood stage malaria vaccine candidates.
    Gray JC; Corran PH; Mangia E; Gaunt MW; Li Q; Tetteh KK; Polley SD; Conway DJ; Holder AA; Bacarese-Hamilton T; Riley EM; Crisanti A
    Clin Chem; 2007 Jul; 53(7):1244-53. PubMed ID: 17510307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic Antigens Derived from
    Pratt-Riccio LR; De Souza Perce-Da-Silva D; Da Costa Lima-Junior J; Pratt Riccio EK; Ribeiro-Alves M; Santos F; Arruda M; Camus D; Druilhe P; Oliveira-Ferreira J; Daniel-Ribeiro CT; Banic DM
    Am J Trop Med Hyg; 2017 Nov; 97(5):1581-1592. PubMed ID: 29016339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A longitudinal study of seroreactivities to a major blood stage antigen (Pf155/RESA) of the malaria parasite Plasmodium falciparum in an endemic area of Thailand.
    Chirakalwasan N; Kamol-Ratanakul P; Lertmaharit S; Perlmann H; Perlmann P; Thaitong S
    Southeast Asian J Trop Med Public Health; 1994 Mar; 25(1):25-31. PubMed ID: 7529944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.